# OU Health – FDA Inspection, Oct 28, 2024

Source: https://www.keypedia.com/records/fda_inspections/ou-health/c53d8da6-7234-40c1-972b-bbf48c478bc2
Source feed: FDA_Inspections

> FDA inspection 1252564 of OU Health, October 28, 2024. Classification: No Action Indicated (NAI). 1 citation under 21 CFR part 1271. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1252564
- Company Name: OU Health
- Inspection Date: 2024-10-28
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Dallas District Office
- Citation Count: 1

## Related Documents

- [FDA Inspection 1091552 - 2019-04-29](https://www.keypedia.com/records/fda_inspections/ou-health/2432bd61-a5d8-4ee2-9557-90eab9ecc2f6)
- FDA Inspection 1021584 - 2017-06-21
- FDA Inspection 909982 - 2014-12-15
- FDA Inspection 808849 - 2012-10-05
- FDA Inspection 725767 - 2011-05-03

## Related Officers

- [Company Rep](https://www.keypedia.com/people/richard-t-riggie/d07a4551-08b4-44f7-b7d2-02ae3c5dc1e2)

Company: https://www.keypedia.com/companies/ou-health/0a6ed5fb-c04d-4f4a-b871-ec96e6d3cbea

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9
